Organon & Co (OGN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $3.65B
Last updated: Nov 17, 2026 at 11:06 AM ET
Organon & Co (OGN) Competitors
The companies most similar to Organon are Grifols SA ADR (GRFS), Ionis Pharmaceuticals (IONS) and Progyny (PGNY). Organon trades at 4.6x earnings, against a median of 27.3x for the 8 of these companies with a P/E. By market cap, Organon ranks 9th of the 13 companies on this page; Johnson & Johnson (JNJ) is the largest at $687.89B.
Peer Comparison
OGN's ROIC of 6.2% is below the peer median of 7.3%, and its revenue growth of -1.7% is below the median of 9.2%. It yields 0.58%, while the median peer pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Organon (OGN) | $3.65B | 4.6x | 0.6x | 3.5% | 6.2% | -1.7% | 0.58% |
| Grifols SA ADR (GRFS) | $5.91B | 9.9x | 0.7x | 6.4% | 7.6% | 9.4% | 1.08% |
| Ionis Pharmaceuticals Inc (IONS) | $4.84B | N/A | 4.8x | -56.9% | -29.3% | 54.9% | 0.00% |
| Progyny Inc (PGNY) | $2.66B | 28.0x | 2.1x | 6.8% | N/A | 8.9% | 0.00% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Biogen Inc (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| TransMedics Group Inc (TMDX) | $3.17B | 70.9x | 4.4x | 19.9% | 7.0% | 41.1% | 0.00% |
| Xenon Pharmaceuticals Inc (XENE) | $3.98B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Iovance Biotherapeutics Inc (IOVA) | $3.59B | N/A | 9.1x | -58.2% | N/A | 80.1% | 0.00% |
| Johnson & Johnson (JNJ) | $687.89B | 26.6x | 6.9x | 16.2% | 12.8% | 5.9% | 1.90% |
| Peer median | $5.38B | 27.3x | 4.4x | 5.0% | 7.3% | 9.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Organon, ranked by how closely their business, size, sector and industry match. The largest group, 6 of the 12, is in Drug Manufacturers - General; the other 6 span 3 industries.
| Company | About | Peers |
|---|---|---|
| Grifols SA ADR (GRFS)Drug Manufacturers - General | Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. | GRFS competitors |
| Ionis Pharmaceuticals Inc (IONS)Biotechnology | Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California. | IONS competitors |
| Progyny Inc (PGNY)Healthcare Plans | Progyny, Inc., a benefits management company, specializes in fertility benefits and family development solutions for employers in the United States. | PGNY competitors |
| Merck & Company Inc (MRK)Drug Manufacturers - General | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| Amgen Inc (AMGN)Drug Manufacturers - General | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| Legend Biotech Corp (LEGN)Biotechnology | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Novo Nordisk A/S (NVO)Drug Manufacturers - General | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| Biogen Inc (BIIB)Drug Manufacturers - General | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development... | BIIB competitors |
| TransMedics Group Inc (TMDX)Medical Devices | TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ... | TMDX competitors |
| Xenon Pharmaceuticals Inc (XENE)Biotechnology | Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders... | XENE competitors |
| Iovance Biotherapeutics Inc (IOVA)Biotechnology | Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness... | IOVA competitors |
| Johnson & Johnson (JNJ)Drug Manufacturers - General | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. | JNJ competitors |
Frequently Asked Questions About OGN
Who are Organon's main competitors?
The companies most similar to Organon include Grifols SA ADR (GRFS), Ionis Pharmaceuticals (IONS), Progyny (PGNY), Merck & Company (MRK) and Amgen (AMGN), listed from the closest match.
Who is Organon's biggest competitor?
Johnson & Johnson (JNJ) is the largest of the similar companies at $687.89B; Grifols SA ADR (GRFS) is the closest match by business profile, size, sector and industry.
How does OGN stock compare with its competitors?
OGN's P/E is 4.6x against a peer median of 27.3x; its P/S is 0.6x against a peer median of 4.4x; its net margin is 3.5% against a peer median of 5.0%.
Which of Organon's competitors pays a higher dividend?
Organon has a forward dividend yield of 0.58%. Novo Nordisk A/S (NVO), Merck & Company (MRK), Amgen (AMGN), Johnson & Johnson (JNJ) and Grifols SA ADR (GRFS) have higher forward dividend yields; Novo Nordisk A/S (NVO) has the highest at 4.32%.
Is Organon bigger than its competitors?
No. Organon is 9th by market cap among the 13 companies on this page; the largest is Johnson & Johnson (JNJ) at $687.89B.
OGN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors